Calcent
Acalabrutinib
- Strength
- 100mg
- Manufacturer
- Incepta Pharma
- Availability
- Available to source
Acalabrutinib 100mg — Capsule, 12's Strip
Need assistance?
Our multilingual healthcare support team can help with availability, shipping and ordering.
Chat on WhatsApp
Scan for WeChat
About this medicine
Originator: Calquence by AstraZeneca · Manufacturer: Incepta Pharma. Indication & Dosage: Calcent (Acalabrutinib), generic Calquence is a prescription medicine used to treat Mantle cell lymphoma (MCL) who have received at least one treatment for their cancer, or Chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL). Calcent manufactured by Incepta Pharma Ltd. in Bangladesh. Acalabrutinib has to take orally twice a day with or without food (about 12 hours apart). Side Effects: The most common adverse reactions (incidence rate ≥ 30%) of Acalabrutinib are: Anemia , neutropenia, upper respiratory tract infection, thrombocytopenia, headache , diarrhea and skeletal muscle pain. The above information comes from the Internet. Please consult with doctor for medical advice.
Indications
This information is provided for reference only and is not medical advice. Always consult a qualified healthcare professional.
